Horizon BioAdvance — Lafayette, Indiana

Horizon BioAdvance is a clinical research site located in Lafayette, Indiana, United States 47905.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Horizon BioAdvance has participated in 3 clinical trials.

Therapeutic areas: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: pharmaand GmbH, Idera Pharmaceuticals, Inc., Endocyte.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lafayette

Browse all research sites in Indiana · View every site in Lafayette

• IU Health Arnett Hospital
• Indiana University Health Arnett Cancer Center ( Site 0076)
• IU Arnett Hospital
• Indiana University
• Indiana University Health - Arnett Cancer Care
• Indiana University Health Arnett
• Indiana University Health Arnett Hospital
• Horizon Oncology Research
• IU Health Arnett Cancer Care
• Horizon Oncology Center
• Franciscan Saint Elizabeth Health - Lafayette East
• Research Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Horizon BioAdvance?

Horizon BioAdvance has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Horizon BioAdvance conducted?

Horizon BioAdvance has 3 clinical trials on record. Their work covers Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Is Horizon BioAdvance accredited by Crixeo Clinical Trials?

Horizon BioAdvance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Horizon BioAdvance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.